Caption Management LLC lessened its holdings in Douglas Elliman Inc. (NYSE:DOUG - Free Report) by 38.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 390,947 shares of the company's stock after selling 244,695 shares during the quarter. Caption Management LLC owned 0.44% of Douglas Elliman worth $672,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Boothbay Fund Management LLC bought a new stake in shares of Douglas Elliman in the fourth quarter valued at about $27,000. Alpine Global Management LLC bought a new stake in shares of Douglas Elliman in the fourth quarter valued at about $28,000. Golden State Wealth Management LLC boosted its position in shares of Douglas Elliman by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 30,000 shares of the company's stock valued at $52,000 after acquiring an additional 15,000 shares during the period. Man Group plc bought a new stake in shares of Douglas Elliman in the fourth quarter valued at about $52,000. Finally, JPMorgan Chase & Co. boosted its position in shares of Douglas Elliman by 79.1% in the fourth quarter. JPMorgan Chase & Co. now owns 38,560 shares of the company's stock valued at $64,000 after acquiring an additional 17,027 shares during the period. Institutional investors own 59.56% of the company's stock.
Douglas Elliman Price Performance
DOUG stock traded up $0.25 during midday trading on Friday, reaching $2.90. The company had a trading volume of 894,485 shares, compared to its average volume of 426,255. The company has a market capitalization of $256.82 million, a price-to-earnings ratio of -3.91 and a beta of 1.77. The stock has a 50 day moving average price of $2.53 and a 200-day moving average price of $2.21. Douglas Elliman Inc. has a 1-year low of $1.35 and a 1-year high of $3.20. The company has a debt-to-equity ratio of 0.35, a current ratio of 3.61 and a quick ratio of 3.61.
Douglas Elliman (NYSE:DOUG - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of $0.03 by ($0.09). The company had revenue of $271.37 million during the quarter, compared to analyst estimates of $333.91 million. Douglas Elliman had a negative net margin of 5.98% and a negative return on equity of 7.11%.
Analyst Ratings Changes
Separately, Wall Street Zen downgraded Douglas Elliman from a "hold" rating to a "sell" rating in a research note on Saturday, August 2nd.
Get Our Latest Research Report on Douglas Elliman
Douglas Elliman Company Profile
(
Free Report)
Douglas Elliman Inc owns Douglas Elliman Realty, LLC, operating as a residential brokerage company in the United States with operations in New York, Florida, California, Texas, Colorado, Nevada, Massachusetts, Connecticut, Maryland, Virginia and Washington, DC In addition, Douglas Elliman sources, uses and invests in early-stage, disruptive property technology (“PropTech”) solutions and companies and provides other real estate services, including development marketing, property management and settlement and escrow services in select markets.
Recommended Stories

Before you consider Douglas Elliman, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Douglas Elliman wasn't on the list.
While Douglas Elliman currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.